Ceramide signaling in the gut.


Journal

Molecular and cellular endocrinology
ISSN: 1872-8057
Titre abrégé: Mol Cell Endocrinol
Pays: Ireland
ID NLM: 7500844

Informations de publication

Date de publication:
15 03 2022
Historique:
received: 07 06 2021
revised: 29 12 2021
accepted: 03 01 2022
pubmed: 10 1 2022
medline: 5 4 2022
entrez: 9 1 2022
Statut: ppublish

Résumé

Sphingolipids are essential lipid components in the intestinal epithelial cells (IEC) along the intestinal tract. They play crucial roles in maintaining barrier integrity, regulating nutrient absorption, and acting as signaling molecules to regulate regeneration and differentiation of intestinal mucosa (Kurek et al., 2012). Ceramide is the central sphingolipid species and the precursor of all complex sphingolipids and other downstream simple intermediates like sphingosine (SPH), ceramide-1-phosphate (C-1-P), and sphingosine-1-phosphate (S-1-P). It is also a critical signaling molecule regulating numerous physiologic and pathologic processes. This review will summarize the metabolism of ceramides in the gut and their regulation in inflammatory bowel diseases and colorectal cancer.

Identifiants

pubmed: 34998898
pii: S0303-7207(22)00001-6
doi: 10.1016/j.mce.2022.111554
pmc: PMC8828712
mid: NIHMS1771468
pii:
doi:

Substances chimiques

Ceramides 0
Lysophospholipids 0
Sphingolipids 0
Sphingosine NGZ37HRE42

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

111554

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK115824
Pays : United States
Organisme : NIDDK NIH HHS
ID : R44 DK116450
Pays : United States
Organisme : NIDDK NIH HHS
ID : R43 DK116450
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK131609
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK130296
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK122001
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK091317
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Références

Nat Med. 2008 Apr;14(4):382-91
pubmed: 18376404
Sci Rep. 2018 Jan 26;8(1):1627
pubmed: 29374263
FEBS Lett. 2002 Aug 28;526(1-3):15-20
pubmed: 12208496
Biochim Biophys Acta. 2007 Feb;1771(2):196-201
pubmed: 17204455
Immunology. 2007 Sep;122(1):54-64
pubmed: 17451462
Prostaglandins Other Lipid Mediat. 2012 Dec;99(3-4):124-30
pubmed: 22940715
Mol Cancer Ther. 2015 Jan;14(1):259-67
pubmed: 25381265
Inflamm Bowel Dis. 2019 Oct 18;25(11):1780-1787
pubmed: 31077307
Cell Death Dis. 2018 Feb 7;9(2):173
pubmed: 29415989
Trends Cell Biol. 2005 Jun;15(6):312-8
pubmed: 15953549
Am J Physiol Gastrointest Liver Physiol. 2001 Jul;281(1):G216-28
pubmed: 11408275
World J Gastroenterol. 2007 Oct 21;13(39):5217-25
pubmed: 17876892
Mol Cell Endocrinol. 2013 Apr 10;368(1-2):17-29
pubmed: 22609541
Cancer Lett. 2006 Apr 8;235(1):141-6
pubmed: 16290921
Prog Lipid Res. 2009 Jan;48(1):62-72
pubmed: 19027789
EMBO J. 1999 Oct 1;18(19):5252-63
pubmed: 10508159
Cell Signal. 2008 Jun;20(6):1010-8
pubmed: 18191382
J Biol Chem. 2003 Oct 3;278(40):38528-36
pubmed: 12885774
Int J Clin Exp Med. 2015 Dec 15;8(12):22529-42
pubmed: 26885239
Inflamm Bowel Dis. 2002 Jul;8(4):258-63
pubmed: 12131609
Nat Commun. 2020 May 18;11(1):2471
pubmed: 32424203
Int J Colorectal Dis. 2003 Jul;18(4):309-13
pubmed: 12774245
Biochim Biophys Acta. 1968 Dec 18;164(3):575-84
pubmed: 5701698
Compr Physiol. 2012 Oct;2(4):2811-28
pubmed: 23720266
Cell Mol Life Sci. 2017 Aug;74(16):3039-3055
pubmed: 28405720
Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Oct;1863(10):1214-1227
pubmed: 30059758
Biochem J. 2006 Feb 15;394(Pt 1):299-308
pubmed: 16255717
Prostaglandins Other Lipid Mediat. 2019 Feb;140:26-30
pubmed: 30550872
Adv Biol Regul. 2014 Jan;54:112-20
pubmed: 24210073
Free Radic Biol Med. 2016 Jun;95:190-9
pubmed: 27016075
Cancer. 1997 Feb 1;79(3):448-53
pubmed: 9028353
Anticancer Res. 2003 Jul-Aug;23(4):3317-22
pubmed: 12926069
FASEB J. 2009 Mar;23(3):751-63
pubmed: 19028839
Dig Dis Sci. 1996 Sep;41(9):1801-6
pubmed: 8794797
Adv Cancer Res. 2018;140:191-215
pubmed: 30060809
Carcinogenesis. 2006 Aug;27(8):1636-44
pubmed: 16501251
Cell Host Microbe. 2019 May 8;25(5):668-680.e7
pubmed: 31071294
Biochem J. 2004 May 1;379(Pt 3):687-95
pubmed: 14731113
J Natl Cancer Inst. 2000 Dec 6;92(23):1897-909
pubmed: 11106681
J Biol Chem. 2001 May 18;276(20):16758-66
pubmed: 11278489
Front Endocrinol (Lausanne). 2020 Jun 19;11:407
pubmed: 32636806
Exp Anim. 2009 Oct;58(5):515-24
pubmed: 19897935
J Biol Chem. 2010 Nov 12;285(46):35706-18
pubmed: 20807762
Gut. 2002 Mar;50(3):307-13
pubmed: 11839706
Mediators Inflamm. 2003 Oct;12(5):277-83
pubmed: 14760934
J Med Chem. 2016 Jun 23;59(12):5904-10
pubmed: 27213958
FASEB J. 2016 Dec;30(12):4159-4171
pubmed: 27609772
J Biol Chem. 2002 Aug 23;277(34):30784-91
pubmed: 12072440
Nature. 2007 Jul 26;448(7152):427-34
pubmed: 17653185
Diabetes. 2017 Mar;66(3):613-626
pubmed: 28223344
Exp Biol Med (Maywood). 2002 May;227(5):345-53
pubmed: 11976405
Cell Microbiol. 2007 May;9(5):1239-51
pubmed: 17223929
J Biol Chem. 2011 Aug 12;286(32):27855-62
pubmed: 21693702
Planta Med. 2007 Jul;73(8):725-30
pubmed: 17583825
Cell Signal. 2021 Feb;78:109860
pubmed: 33271224
J Clin Med. 2019 Jul 04;8(7):
pubmed: 31277430
BMC Med Genomics. 2016 Sep 08;9(1):58
pubmed: 27609023
J Clin Invest. 2015 Jan;125(1):386-402
pubmed: 25500885
Chem Phys Lipids. 1999 Nov;102(1-2):97-105
pubmed: 11001564
Cell Death Differ. 2018 May;25(5):841-856
pubmed: 29229990
Dig Dis. 2015;33(3):327-31
pubmed: 26045265
Nat Rev Cancer. 2004 Aug;4(8):604-16
pubmed: 15286740
Expert Rev Gastroenterol Hepatol. 2020 Jan;14(1):47-54
pubmed: 31874053
Gut. 2006 Mar;55(3):342-7
pubmed: 16000642
Cell. 2019 May 30;177(6):1536-1552.e23
pubmed: 31150623
Nat Commun. 2015 Dec 15;6:10166
pubmed: 26670557
Biochim Biophys Acta. 1993 Dec 21;1154(3-4):223-36
pubmed: 8280742
Nature. 2003 Dec 18;426(6968):803-9
pubmed: 14685229
Mol Cell Biol. 2013 Jun;33(11):2353-69
pubmed: 23547262
Nat Genet. 2010 Apr;42(4):332-7
pubmed: 20228799
Inflamm Bowel Dis. 2005 Jan;11(1):1-7
pubmed: 15674107
Mol Cancer Ther. 2006 Jun;5(6):1520-9
pubmed: 16818511
Biochim Biophys Acta. 2014 May;1841(5):671-81
pubmed: 24021978
Oncogene. 2009 Feb 26;28(8):1132-41
pubmed: 19137010
J Nutr. 1994 May;124(5):702-12
pubmed: 8169662
Adv Cancer Res. 2018;140:1-25
pubmed: 30060806
Cell Rep. 2018 Mar 6;22(10):2702-2715
pubmed: 29514098
Exp Mol Pathol. 2015 Jun;98(3):585-92
pubmed: 25779024
Trends Mol Med. 2017 Apr;23(4):362-374
pubmed: 28283249
Sci Rep. 2020 Apr 9;10(1):6124
pubmed: 32273521
J Biol Chem. 2002 Jul 19;277(29):25843-6
pubmed: 12011104
Postepy Hig Med Dosw (Online). 2012 Nov 15;66:868-75
pubmed: 23175343
Lipids Health Dis. 2015 Oct 22;14:130
pubmed: 26493087
Cancer Res. 2001 Feb 1;61(3):1233-40
pubmed: 11221856
Nat Rev Cancer. 2018 Jan;18(1):33-50
pubmed: 29147025
Oncol Rep. 2015 Jul;34(1):447-54
pubmed: 25975960
Br J Nutr. 2004 May;91(5):715-23
pubmed: 15137923
J Lipid Res. 2003 Jun;44(6):1241-50
pubmed: 12671034
Biochem Pharmacol. 2010 Dec 1;80(11):1632-40
pubmed: 20735991
Gut. 2010 Jan;59(1):69-78
pubmed: 19828471
J Lipid Res. 2018 Mar;59(3):515-530
pubmed: 29343537
J Lipid Res. 2005 Sep;46(9):1944-52
pubmed: 15961787
Oncol Rep. 2018 Dec;40(6):3489-3500
pubmed: 30272337
Sci Rep. 2013;3:1035
pubmed: 23301156
Chem Biol. 2015 Dec 17;22(12):1662-70
pubmed: 26687483
Nat Med. 2004 Feb;10(2):155-60
pubmed: 14704790
PLoS Genet. 2007 Apr 20;3(4):e58
pubmed: 17447842
Toxicol Sci. 2004 Jan;77(1):165-71
pubmed: 14600282
Br J Cancer. 1999 Sep;81(2):232-6
pubmed: 10496347
Cell Death Dis. 2016 Mar 03;7:e2124
pubmed: 26938296
J Cell Mol Med. 2017 Dec;21(12):3565-3578
pubmed: 28699686
Mayo Clin Proc. 2019 Jan;94(1):155-165
pubmed: 30611442

Auteurs

Ying Li (Y)

Department of Nutrition and Integrative Physiology and the Diabetes and Metabolism Research Center, University of Utah, 15 North 2030 East, UT, 84112, Salt Lake City, USA. Electronic address: li.ying@utah.edu.

Rebekah J Nicholson (RJ)

Department of Nutrition and Integrative Physiology and the Diabetes and Metabolism Research Center, University of Utah, 15 North 2030 East, UT, 84112, Salt Lake City, USA.

Scott A Summers (SA)

Department of Nutrition and Integrative Physiology and the Diabetes and Metabolism Research Center, University of Utah, 15 North 2030 East, UT, 84112, Salt Lake City, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH